UK markets closed

Theravance Biopharma, Inc. (TBPH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.12-0.02 (-0.22%)
At close: 04:00PM EDT
8.88 -0.24 (-2.63%)
After hours: 04:05PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
57,424
57,424
51,346
55,311
71,857
Cost of revenue
-
-
-
-
0
Gross profit
-
-
-
-
71,857
Operating expenses
Research development
40,621
40,621
63,392
193,657
260,953
Selling general and administrative
70,095
70,452
74,071
107,658
108,531
Total operating expenses
110,716
111,073
137,463
301,315
369,484
Operating income or loss
-53,292
-53,649
-86,117
-246,004
-297,627
Interest expense
2,350
2,350
6,369
8,547
8,547
Total other income/expenses net
-2,743
-2,386
-8,874
-11,780
-1,610
Income before tax
-49,269
-49,269
-92,815
-265,222
-303,343
Income tax expense
5,924
5,924
9
-151
-8,520
Income from continuing operations
-55,193
-55,193
-92,824
-265,071
-294,823
Net income
-55,193
-55,193
872,132
-199,426
-278,017
Net income available to common shareholders
-55,193
-55,193
872,132
-199,426
-278,017
Basic EPS
-0.62
-
11.85
-2.87
-4.46
Diluted EPS
-0.62
-
11.85
-2.87
-4.46
Basic average shares
59,798
-
73,591
69,461
62,345
Diluted average shares
59,798
-
73,591
69,461
62,345